Search
SOLACI Congress
HomeCONGRESS

CONGRESS

View Category
Other

ESC 2024 | TRI.Fr: Transcatheter Tricuspid Repair for the Treatment of Tricuspid Regurgitation

Right-sided heart failure and tricuspid regurgitation (TR) are associated with poor quality of life and an increased...
Dr. Omar Tupayachi -
Learn More
Mitral valve

ESC 2024 | MATERHORN Trial: Transcatheter vs. Surgical Mitral Repair in Patients with Heart Failure and Secondary Mitral Regurgitation

European guidelines consider transcatheter therapy as an alternative for patients with secondary mitral regurgitation who are not...
Dr. Omar Tupayachi -
Learn More
Mitral valve

ESC 2024 | RESHAPE-HF2: MitraClip in Heart Failure and Moderate to Severe Mitral Regurgitation

The aim of this study was to assess the effectiveness of MitraClip in patients with secondary mitral...
Dr. Omar Tupayachi -
Learn More
Antiplatelet

ESC 2024 | QUADRO Trial: Efficacy and Safety of the First Quadruple Therapy Single Pill in Resistant Hypertension Patients

Researchers conducted an international, randomized, parallel-group study with a superiority design over a 16-week period. The doses...
Dr. Omar Tupayachi -
Learn More
Other

ESC 2024 | STOP-or-NOT Trial: Optimal Management of Renin-Angiotensin System Inhibition Before Non-Cardiac Surgery

Researchers conducted a multicenter, randomized study to assess the continuation of renin-angiotensin system inhibition (RASI) before major...
Dr. Omar Tupayachi -
Learn More
Acute coronary syndromes

ESC 2024 | AßYSS: Discontinuation of Beta-Blocker Treatment After One Year in Uncomplicated MI

Researchers presented a non-inferiority study conducted at 49 centers in France, with a randomized cohort of stable post-acute...
Dr. Omar Tupayachi -
Learn More
Institutional News

SOLACI-CACI 2024 – Presentations day 3

Discover the highlights of the third day of activities of  SOLACI-CACI 2024 Congress, held from August 7 to 9 at...
solaci -
Learn More
Institutional News

SOLACI-CACI 2024 – Day 2 Presentations

Discover the highlights of the second day of activities of  SOLACI-CACI 2024 Congress, held from August 7 to 9 at...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Long Term Results of the International Chimney Registry

Dr. Omar Tupayachi - 0
The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

Dr. Omar Tupayachi - 0
The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

Dr. Omar Tupayachi - 0
The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...

Institutional News

Hemodynamics and Interventional Cardioangiology Hybrid Training Course SOLACI-CACI

solaci - 0
We are now open for registration to the hybrid training course on Hemodynamics and Interventional Cardioangiology for Technicians and Nurses SOLACI-CACI 2025 Find all course...

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy